MoneyWorks4Me

Aurobindo Pharma informs about disclosure

03 Apr 2024 Evaluate

Aurobindo Pharma has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Axis Trustee Services.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1746.75
Dr. Reddys Labs. 1179.00
Cipla 1296.70
Lupin 1945.95
Zydus Lifesciences 1116.10
View more..